SMAD3 and osteosarcoma: Inhibiting SRC activated by TGF-β1 impaired the activation of ERK, Smad2, and Smad3, as well as Smad nuclear translocation, which, in turn, inhibited the induction of CTGF in rat osteosarcoma osteoblast-like cells [75].